Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies

During a keynote presentation at the 2025 GenScript Biotech Global Forum, CAR T cell therapy pioneer Carl June, MD, the Richard W. Vague Professor in Immunotherapy, shared his perspective on 2024 being a breakthrough year for cell and gene therapies. He noted the remarkable progress in CAR T cell therapy for glioblastoma—including a Penn-led clinical trial—and for early-stage autoimmune diseases.